Showing results (61-70 of 170) with videos related to
Sort By:
Pageof 17
Journal of the International AIDS Society|September 28, 2023
Clinical outcomes after extended 12-month antiretroviral therapy prescriptions in a community-based differentiated HIV service delivery programme in South Africa: a retrospective cohort studyLara Lewis, Yukteshwar Sookrajh, Johan van der Molen, et al.Journal of the International AIDS Society|July 15, 2025
Cost and clinical flow of point-of-care urine tenofovir testing for treatment monitoring among people living with HIV initiating ART in South AfricaMelody Wang, Pravikrishnen Moodley, Mlungisi Khanyile, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 26, 2026
Earlier referral to differentiated antiretroviral therapy delivery at six months after initiation: a retrospective cohort study in KwaZulu-Natal, South AfricaJohan van der Molen, Kwena Tlhaku, Lara Lewis, et al.Open Forum Infectious Diseases|December 4, 2023
Clinical Outcomes After Viremia Among People Receiving Dolutegravir vs Efavirenz-Based First-line Antiretroviral Therapy in South AfricaKwabena Asare, Lara Lewis, Johan van der Molen, et al.Journal of the International AIDS Society|July 23, 2025
Long-term usage patterns and clinical outcomes in a community-based differentiated antiretroviral therapy delivery programme in South AfricaLara Lewis, Yukteshwar Sookrajh, Johan van der Molen, et al.BMC Immunology|July 21, 2023
Blood monocyte and dendritic cell profiles among people living with HIV with Mycobacterium tuberculosis co-infectionSanthuri Rambaran, Thando Glory Maseko, Lara Lewis, et al.International Journal of Microbiology|January 28, 2022
High-Resolution Melting Analysis to Detect Antimicrobial Resistance Determinants in South African Neisseria gonorrhoeae Clinical Isolates and SpecimensNireshni Mitchev, Ravesh Singh, Veron Ramsuran, et al.Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
Clinical outcomes after the introduction of dolutegravir for second-line antiretroviral therapy in South Africa: a retrospective cohort studyKwabena Asare, Yukteshwar Sookrajh, Johan van der Molen, et al.The Lancet. Global Health|December 24, 2023
Clinical outcomes with second-line dolutegravir in people with virological failure on first-line non-nucleoside reverse transcriptase inhibitor-based regimens in South Africa: a retrospective cohort studyKwabena Asare, Yukteshwar Sookrajh, Johan van der Molen, et al.International Journal of Microbiology|October 31, 2022
Assessment of Antibiotic Resistance and Efflux Pump Gene Expression in Neisseria Gonorrhoeae Isolates from South Africa by Quantitative Real-Time PCR and Regression AnalysisNireshni Mitchev, Ravesh Singh, Veron Ramsuran, et al.Pageof 17